Navigation Links
Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate
Date:6/19/2013

WASHINGTON, June 19, 2013 /PRNewswire/ -- U.S. Secretary of State John Kerry today presided over a ceremony at which distinguished Syngenta scientist Mary-Dell Chilton, Ph.D., was named a laureate of the prestigious 2013 World Food Prize. The prize is the foremost international award recognizing individuals who have enhanced human development by improving the quality, quantity or availability of food in the world.

Dr. Chilton and two other laureates were recognized for "revolutionary biotechnology discoveries that unlocked the key to plant cell transformation." Dr. Chilton's groundbreaking molecular research showed how a plant bacterium could be adapted as a tool to insert genes from another organism into plant cells, which could produce crop varieties with new innovative traits.  As a direct consequence of this work, in 1996 Ciba-Geigy - now Syngenta - became the first company to commercialize a GM trait in corn. By 2012, transgenic crops were being grown on more than 170 million hectares by more than 17 million farmers.

Mike Mack, Syngenta CEO said, "Mary-Dell Chilton exemplifies Syngenta's corporate purpose - bringing plant potential to life. She is a pioneer of modern biotechnology, which is a key component of the integrated solutions that will help farmers meet the rising food, feed and fuel demands of a fast-growing global population." 

Dr. Chilton founded Syngenta's biotech research center at Research Triangle Park in 1984 and is today a Distinguished Science Fellow of Syngenta Biotechnology Inc.  She will be formally awarded the World Food Prize at the 27th Annual Laureate Award Ceremony in Des Moines, Iowa on October 17.

About Syngenta
Syngenta is one of the world's leading companies with more than 27,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers, we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us, please go to www.syngenta.com.

Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties including the "Risk Factors" in our Annual Report on Form 20-F. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract thereof.

The Syngenta logo is a registered trademark of a Syngenta Group Company.


'/>"/>
SOURCE Syngenta
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority
2. Neogen announces Bohannon retirement, successor named
3. SoundConnect Named Adobe Connect Channel Partner
4. Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine
5. Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group
6. St. Jude scientist named Howard Hughes Medical Institute investigator
7. CellHealth Institute is Named 2013 Edison Award Winner
8. Health Decisions CEO Michael Rosenberg Named a Business Leader Top Entrepreneur for 2013
9. Street Named After EMCO High Voltage Corporation
10. Serial Entrepreneur Ken Malone Named BHI Entrepreneur-in-Residence to Offer Commercialization Guidance to Start-Ups Based on UM Discoveries
11. Roberto DellOro Named Director of LMUs Bioethics Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... March 23, 2017  BioPharmX Corporation (NYSE MKT: ... the dermatology market, today reported financial results for ... and will provide an update on the company,s ... "We are pleased to report that ... BioPharmX," said President Anja Krammer. "We achieved key ...
(Date:3/23/2017)... , March 23, 2017  Agriculture technology company ... A financing and note conversion to commercialize its Cool ... is focused on developing products that are simultaneously profitable ... million in the last 18 months. This latest round ... Bridge Venture Partners. The company,s primary ...
(Date:3/22/2017)... 22, 2017  Ascendis Pharma A/S (Nasdaq: ASND), ... technology to address significant unmet medical needs in ... full year ended December 31, 2016. ... company as we broadened our pipeline and pursued ... disease company with an initial focus on endocrinology," ...
(Date:3/22/2017)... March 22, 2017 The global ... a research report by Transparency Market Research (TMR). The ... Inc., and AbbVie Inc., accounted for a share of ... players in this market are focusing aggressively on mergers, ... which is likely to lead to market consolidation in ...
Breaking Biology Technology:
(Date:2/24/2017)... Spain , Feb. 24, 2017  EyeLock LLC, a ... demonstrate its elite iris biometric solution on the ... X16 LTE at Mobile World Congress 2017 ... Qualcomm,s Booth in Hall 3, Stand 3E10. ... the Qualcomm Haven™ security platform—a combination of ...
(Date:2/16/2017)... FRANCISCO , Feb. 16, 2017  Genos, ... today announced that it has received Laboratory Accreditation ... CAP Accreditation is presented to laboratories that meet ... who demonstrate scientifically rigorous processes. "Genos ... excellence in laboratory practices. We,re honored to be ...
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
Breaking Biology News(10 mins):